Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
3
60%
Ph early_phase_1
1
20%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(2)
Terminated(2)
Other(1)

Detailed Status

Completed2
Terminated1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (20.0%)
Phase 21 (20.0%)
N/A3 (60.0%)

Trials by Status

terminated120%
unknown120%
completed240%
withdrawn120%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients

NCT02701582
withdrawnnot_applicable

Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%

NCT01849757
unknownearly_phase_1

Different Preloads for Prevention of Hypotension in Patients Undergoing Elective CS Under Intrathecal Anesthesia

NCT03465943
terminatednot_applicable

Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty

NCT01452581
completedphase_2

Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization

NCT00317512

Clinical Trials (5)

Showing 5 of 5 trials
NCT02701582Not Applicable

Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients

Completed
NCT01849757Not Applicable

Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%

Withdrawn
NCT03465943Early Phase 1

Different Preloads for Prevention of Hypotension in Patients Undergoing Elective CS Under Intrathecal Anesthesia

Unknown
NCT01452581Not Applicable

Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty

Terminated
NCT00317512Phase 2

Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5